Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

File A4184 ("Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.") is before the New Jersey Legislature and has not been decided. Latest step (February 19, 2026): Introduced, Referred to Assembly Health Committee.

New Jersey file A4184, before the New Jersey Legislature. No action in 274 days as of 2026-02-19.

Read the official record for A4184

See everything up for a vote · This week in New Jersey · See what we have filed with the clerk